Search research articles
Contact Us
Filters
Showing results (311-320 of 593) with videos related to
Page
of 60
Sort By:
Obesity Surgery
|
February 18, 2016
Indications and Operative Outcomes of Gastric Bypass Reversal
Hinali Zaveri, Ramsey M Dallal, Daniel Cottam, et al.
Neuropharmacology
|
November 10, 2019
Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats
Sarah J Cross, Daisy D Reynaga, Michelle Cano, et al.
Scientific Reports
|
October 18, 2017
Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
V Blair Journigan, Willma E Polgar, Edward W Tuan, et al.
Neuropharmacology
|
June 4, 2026
NOP receptor activation counteracts stress-induced migraine-like behaviors in mice
Pietro Pola, Chiara Sturaro, Michela Argentieri, et al.
BMC Women'S Health
|
October 22, 2018
Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories
Toral Zaveri, Kimberly A Powell, Kate M Guthrie, et al.
Epilepsia
|
April 6, 2017
Network evolution in mesial temporal lobe epilepsy revealed by diffusion tensor imaging
Helen Wang, Yuegao Huang, Daniel Coman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 2010
The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward
Taline V Khroyan, Willma E Polgar, Gerta Cami-Kobeci, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 30, 2006
SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice
Taline V Khroyan, Nurulain T Zaveri, Willma E Polgar, et al.
Addiction Biology
|
June 22, 2017
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Marsida Kallupi, Qianwei Shen, Giordano de Guglielmo, et al.
Reproductive Biomedicine Online
|
September 6, 2011
Identification and validation of candidate biomarkers involved in human ovarian autoimmunity
Purvi V Mande, Firuza R Parikh, Indira Hinduja, et al.
Page
of 60
Search research articles
Search
Showing results (311-320 of 593) with videos related to
Sort By:
Page
of 60
Obesity Surgery
|
February 18, 2016
Indications and Operative Outcomes of Gastric Bypass Reversal
Hinali Zaveri, Ramsey M Dallal, Daniel Cottam, et al.
Neuropharmacology
|
November 10, 2019
Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats
Sarah J Cross, Daisy D Reynaga, Michelle Cano, et al.
Scientific Reports
|
October 18, 2017
Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
V Blair Journigan, Willma E Polgar, Edward W Tuan, et al.
Neuropharmacology
|
June 4, 2026
NOP receptor activation counteracts stress-induced migraine-like behaviors in mice
Pietro Pola, Chiara Sturaro, Michela Argentieri, et al.
BMC Women'S Health
|
October 22, 2018
Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories
Toral Zaveri, Kimberly A Powell, Kate M Guthrie, et al.
Epilepsia
|
April 6, 2017
Network evolution in mesial temporal lobe epilepsy revealed by diffusion tensor imaging
Helen Wang, Yuegao Huang, Daniel Coman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 2010
The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward
Taline V Khroyan, Willma E Polgar, Gerta Cami-Kobeci, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 30, 2006
SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice
Taline V Khroyan, Nurulain T Zaveri, Willma E Polgar, et al.
Addiction Biology
|
June 22, 2017
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Marsida Kallupi, Qianwei Shen, Giordano de Guglielmo, et al.
Reproductive Biomedicine Online
|
September 6, 2011
Identification and validation of candidate biomarkers involved in human ovarian autoimmunity
Purvi V Mande, Firuza R Parikh, Indira Hinduja, et al.
Page
of 60